BTG (LON:BTG) said it agreed to put a total of $110 million on the table for Galil Medical and its line of cryoablation devices for treating cancer. The deal calls for London-based BTG to pay $84.5 million (£58.3 million) in up-front cash and another $25.5 million (£17.6 million) in regulatory and commercial milestones, which are […]
BTG
Philips, BTG tout 1st live-imaging embo bead procedure
Royal Philips (NYSE:PHG) and BTG said today the 1st patient has been treated by a live-image guided LC Bead Lumi in a treatment aiming to block blood flow to a hypervascular tumor in a patient with liver cancer. BTG’s LC Bead Lumis are embolic beads which can be visualized during interventional procedures to allow operating […]
BTG wins FDA 510(k) for radiopaque beads, touts PneumRx coil study
BTG said today it won FDA 510(k) clearance for its LC Bead Lumi radiopaque embolic beads designed for embolization of hypervascular tumors and arteriovenous malformations and touted results from the Renew study of its PneumRx endobronchial coil implant. The Lumi was designed with radiopacity tech that allows for real-time tracking of bead location during embolization procedures, London-based BTG […]